These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 791550)

  • 1. In vitro reversal of cellular unresponsiveness induced by levamisole.
    Golding H; Golding B; Jacobson R; Lomnitzer R; Koornhof HJ; Rabson AR
    Clin Exp Immunol; 1976 Nov; 26(2):295-301. PubMed ID: 791550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
    Basch CM; Spitler LE; Engleman EG; Engleman EP
    J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity in sarcoidosis: effect of corticosteroids.
    Gross NJ; Holt PJ
    Br J Dis Chest; 1977 Jan; 71(1):25-34. PubMed ID: 318850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of levamisole on the lymphocyte and macrophage activity in carp (Cyprinus carpio).
    Siwicki AK; Cossarini-Dunier M
    Ann Rech Vet; 1990; 21(2):95-100. PubMed ID: 2360777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro.
    Lichtenfeld JL; Desner MR; Wiernik PH; Mardiney MR
    Cancer Treat Rep; 1976 May; 60(5):571-4. PubMed ID: 991144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactivating effect of levamisole on cell-mediated immunity in gastrointestinal cancer patients.
    Miwa H; Orita K
    Acta Med Okayama; 1977 Oct; 31(5):325-9. PubMed ID: 146404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preoperative immunochemotherapy for gastric cancer patients--immunomodulating effect of levamisole and lentinan on cell-mediated immunity and regional lymph node].
    Takeshita M; Kobori T; Sudo E; Miyamoto Y; Izuo M
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1052-60. PubMed ID: 7184439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levamisole and cellular immunity in rheumatoid arthritis--clinical and laboratory correlates.
    Levy J
    J Rheumatol Suppl; 1978; 4():63-70. PubMed ID: 366145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of levamisole on cellular immunity in multiple sclerosis.
    Dau PC; Johnson KP; Spitler LE
    Clin Exp Immunol; 1976 Nov; 26(2):302-9. PubMed ID: 991460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of the administration of levamisole on the reactivity of T-lymphocytes in advanced cancer patients].
    Renoux G; Renoux M
    Nouv Presse Med; 1976 Jan; 5(2):67-70. PubMed ID: 772602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.
    Newberry WM; Sanford JP
    J Clin Invest; 1971 Jun; 50(6):1262-71. PubMed ID: 5578233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
    Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
    Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid.
    Joffe MI; Sukha NR; Rabson AR
    J Clin Invest; 1983 Sep; 72(3):971-80. PubMed ID: 6604071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levamisole on interferon production by PHA-stimulated human leukocyte cultures.
    Rhodes-Feuillette A; Canivet M; Andrieu JM; Périès J
    Biomedicine; 1979 Oct; 31(6):170-2. PubMed ID: 526537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inhibitor of lymphocyte proliferation and lymphokine production released by unstimulated foetal monocytes.
    Wolf RL; Lominitzer R; Rabson AR
    Clin Exp Immunol; 1977 Mar; 27(3):464-8. PubMed ID: 862232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levamisole-induced immunitary responses in patients operated from bronchogenic carcinoma (author's transl)].
    Wipf R; Stinghe R; Girard JP
    Poumon Coeur; 1979; 35(4):189-93. PubMed ID: 504048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.